Company news
Jasper Therapeutics, Inc. news in 2022
Jasper Therapeutics, Inc.'s news releases, calls and decks from 2022, newest first.
Jasper Therapeutics Reports Third Quarter 2022 Financial Results and Provides a Corporate Update
November 9, 2022
Jasper Therapeutics Announces Positive Clinical Data from Investigator Sponsored Study of JSP191 Conditioning in Fanconi Anemia Patients at IEWP Annual Meeting
September 25, 2022
Jasper Therapeutics Announces FDA Fast Track Designation for JSP191, a novel monoclonal antibody targeting CD117, in the treatment of patients with severe combined immunodeficiency (SCID) undergoing allogeneic hematopoietic stem cell transplant
September 14, 2022
Jasper Therapeutics Reports Second Quarter 2022 Financial Results and Provides a Corporate Update
August 11, 2022
Jasper Therapeutics Announces Annual Virtual Stockholders Meeting to be Held on Thursday, June 23, 2022
June 5, 2022
Jasper Therapeutics Announces Treatment of First Patient in Study of JSP191 Conditioning in Patients with Fanconi Anemia
May 16, 2022
Jasper Therapeutics Reports First Quarter 2022 Financial Results and Provides a Corporate Update
May 11, 2022
Jasper Therapeutics Announces Plans for Registrational Study of JSP191 in Older Patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia Undergoing Hematopoietic Cell Transplantation after Type C FDA Meeting
April 27, 2022
Jasper Therapeutics Announces Updated Data from Phase 1 Clinical Trial of JSP191 as Targeted Stem Cell Conditioning Agent in Older Patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia Undergoing Hematopoietic Cell Transplantation
April 25, 2022
Jasper Therapeutics Announces Management Changes to Strengthen Leadership Team
March 20, 2022
Jasper Therapeutics Announces Fiscal 2021 Financial Results and Provides Business Update
March 17, 2022
Jasper Therapeutics Announces Appointment of Ronald Martell as Chief Executive Officer
February 27, 2022
Jasper Therapeutics Announces JSP191 Phase 1b MDS/AML Late Breaking Data Presentation at the 2022 Transplantation & Cellular Therapy Tandem Meetings of ASTCT and CIBMTR
February 23, 2022
Decks in 2022
- Technical Presentation (April 2022)
Technical · 18 slides · Apr 27, 2022
- Investor Presentation (March 2022)
Investor deck · 8 slides · Mar 16, 2022